REG - Spire Healthcare Grp - Announcement of the passing of a Director

Spire HealthcareAnnouncement

05/09/2024 10:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240905:nRSE0630Da&default-theme=true

RNS Number : 0630D  Spire Healthcare Group PLC  05 September 2024

 

5 September 2024

 

Spire Healthcare Group plc

('Spire Healthcare', 'the Company' or 'the Group')

 

Spire Healthcare Group plc announces the passing of Martin Angle, Deputy
Chairman and Independent Non-Executive Director

 

It is with great sorrow that Spire Healthcare announces that Martin Angle,
Deputy Chairman and independent Non-Executive Director of the Company, passed
away on Monday, 2 September 2024. Mr Angle served as a member of the Board
from March 2019 and was Chair of the Audit and Risk Committee and a member of
the Clinical Governance and Safety Committee, Nomination and Remuneration
Committees.

 

Sir Ian Cheshire, Non-Executive Chairman, and Justin Ash, Chief Executive
Officer, commented: "It is with deep sadness that we learned of the passing of
our dear friend and colleague, Martin Angle, earlier this week. Martin was a
highly respected, valued and trusted member of our Board and a personal friend
to us both and many others at Spire Healthcare. He will be sorely missed by
all who had the privilege of knowing him. Our deepest sympathies and
condolences are with Martin's family at this difficult time."

 

- Ends -

 

For further information please contact:

 

Spire Healthcare Group plc

Mantraraj Budhdev - Group General Counsel and Company Secretary

 

+44 (0)7787 28 38 48

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAUVAWRSAUKRRR